Skip to main content
. 2014 Feb 18;9(2):e88867. doi: 10.1371/journal.pone.0088867

Table 1. Patient demographics in the three study groups and in the three control groups.

Group 1 (1.5 ml/kg) Group 2 (1.0 ml/kg) Group 3 (0.5 ml/kg) Control 1 Control 2 Control 3 p-value
Sex (m/f) 9/11 12/8 9/11 9/11 12/8 9/11 .794
Age (years) 62 (57–69) 73 (59–78) 69 (55–76) 62 (57–69) 73 (59–78) 69 (55–76) .379
BW (kg) 78 (67–88) 78 (70–88) 76 (66–85) 70 (66–84) 79 (69–94) 75 (66–85) .789
Height (m) 1.70 (1.64–1.76) 1.69 (1.62–1.75) 1.66 (1.59–1.70) 1.64 (1.58–1.72) 1.70 (1.65–1.75) 1.66 (1.60–1.76) .314
BMI (kg/m2) 26.3 (24.6–29.2) 26.1 (23.7–32.2) 28.0 (26.3–30.1) 28.0 (24.4–31.1) 27.4 (24.4–31.1) 26 (24.3–29.0) .749
CMV (ml) 117 (101–137) 78 (70–88) 39 (33–43) 80 80 80
TID (mg) 31 455 (27 135–36 855) 21 060 (18 900–23 625) 10 395 (8 978–11 610) 21 600 21 600 21 600
RID (mg/kg BW) 405 270 135 305 (255–322) 274 (230–316) 288 (256–329)

Data on age, BW, height, BMI, CMV, TID, and RID are presented as medians (25th percentile–75th percentile); BW – body weight; BMI – body mass index; CMV – contrast medium volume; TID – total iodine dose; RID – relative iodine dose. Overall p-value was calculated by Kruskal-Wallis test.